CDK2 and cancer: Our results suggest that miR-302a acts as a tumor suppressor and suppresses the cancer-stemness signature in cancer cells by suppressing target genes such as CDK2 and BMI-1, although it has an important role in maintaining stemness in pluripotent cells such as ES cells and iPS cells.